Toward the establishment of more suitable strain of Lucilia sericata for maggot debridement therapy.
Project/Area Number |
15K19088
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Parasitology (including sanitary zoology)
|
Research Institution | Jikei University School of Medicine |
Principal Investigator |
Aonuma Hiroka 東京慈恵会医科大学, 医学部, 助教 (60451457)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 創傷治癒 / マゴットセラピー / ヒロズキンバエ / 衛生動物 |
Outline of Final Research Achievements |
Maggot debridement therapy (MDT) is one of biotherapy that involves the application of green bottle fly, Lucilia sericata, larvae (Maggot) to the necrotic wounds. Maggot application to the wound promotes removal of necrotic tissues, disinfection, and healing. Toward the establishment of more suitable strain of fly for MDT, a measure to evaluate the ability of maggot for debridement has been developed. Controlling maggot pupation by reducing acdysteroids was also examined, which could be lead to the extension of days between each treatment. Establishment of more suitable maggot strain could potentially improve therapeutic effect and patient outcome with MDT.
|
Report
(3 results)
Research Products
(7 results)